Palantir a high-risk investment with ’a one-of-a-kind growth and margin model’
In a recent filing with the Securities and Exchange Commission, Kellanova (NYSE:K) disclosed that the W.K. Kellogg Foundation Trust executed a significant stock sale. On March 28, 2025, the trust sold 114,583 shares of Kellanova common stock at an average price of $82.44 per share. This transaction amounted to a total value of approximately $9.4 million. The sale comes as Kellanova trades near its 52-week high of $83.22, with the stock showing impressive momentum through a 48% gain over the past year. The company maintains a solid market capitalization of $28.5 billion and has demonstrated its commitment to shareholders through 55 consecutive years of dividend payments.
Following this sale, the W.K. Kellogg Foundation Trust, which lists LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas, and The Northern Trust (NASDAQ:NTRS) Company as trustees, retains ownership of 47,389,114 shares. The sales were conducted under a pre-arranged trading plan established on May 7, 2024, in compliance with Rule 10b5-1(c) under the Securities and Exchange Act of 1934. According to InvestingPro, Kellanova currently maintains a "GOOD" Financial Health score, with analysts forecasting continued profitability for the year ahead. For detailed analysis and additional insights, investors can access the comprehensive Pro Research Report, available exclusively to InvestingPro subscribers.
In other recent news, Kellanova has successfully secured the necessary consents to amend the terms of its outstanding notes, moving closer to finalizing its merger with Mars, Incorporated. This strategic merger will result in Kellanova becoming a wholly-owned subsidiary of Mars, enhancing its business operations and financial backing. Meanwhile, Kellanova’s Board of Directors has approved the grant of restricted stock units (RSUs) to its top executives as part of a long-term incentive plan, aligning their interests with those of shareholders. CEO Mr. Cahillane and other executives received significant RSU awards, which will vest on the third anniversary of the grant date.
Additionally, DA Davidson has maintained a Neutral rating on Kellanova with a price target of $83.50, despite the company’s strong performance in fiscal year 2024. Kellanova’s fourth-quarter earnings exceeded expectations, largely due to reduced administrative expenses following the Mars acquisition announcement. The company’s organic net sales also surpassed forecasts, driven by growth in the AMEA region. However, DA Davidson noted a weakening market response in North America and Europe. These developments reflect Kellanova’s ongoing strategic maneuvers and financial achievements in the competitive landscape.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.